Home/Filings/4/0001209191-22-039329
4//SEC Filing

Viney Joanne L. 4

Accession 0001209191-22-039329

CIK 0001708493other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 6:50 PM ET

Size

8.3 KB

Accession

0001209191-22-039329

Insider Transaction Report

Form 4
Period: 2022-06-22
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2022-06-22+10,16710,167 total
    Exercise: $2.01Exp: 2032-06-21Common Stock (10,167 underlying)
  • Award

    Director Stock Option (Right to Buy)

    2022-06-22$1.40/sh+37,500$52,50037,500 total
    Exercise: $2.01Exp: 2032-06-21Common Stock (37,500 underlying)
Footnotes (3)
  • [F1]The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.
  • [F2]This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $52,500 ("Election Option").
  • [F3]One-half of the Election Option vested and became exercisable on June 22, 2022, and 25% of each Election Option will vest and become exercisable on each of September 30, 2022 and December 31, 2022, subject to the continuous service of the Reporting Person with the Issuer on each vesting date.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001816744

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:50 PM ET
Size
8.3 KB